BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
2732157
Number of visits today
171
Number of downloads
2002978
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Lejman M, Kuśmierczuk K, Bednarz K, Ostapińska K, Zawitkowska J. Targeted Therapy in the Treatment of Pediatric Acute Lymphoblastic Leukemia-Therapy and Toxicity Mechanisms. Int J Mol Sci 2021;22:9827. [PMID: 34575992 DOI: 10.3390/ijms22189827] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bernsen EC, Hogenes VJ, Nuijen B, Hanff LM, Huitema ADR, Diekstra MHM. Practical Recommendations for the Manipulation of Kinase Inhibitor Formulations to Age-Appropriate Dosage Forms. Pharmaceutics 2022;14. [PMID: 36559327 DOI: 10.3390/pharmaceutics14122834] [Reference Citation Analysis]
2 Kyriakidis I, Mantadakis E, Stiakaki E, Groll AH, Tragiannidis A. Infectious Complications of Targeted Therapies in Children with Leukemias and Lymphomas. Cancers (Basel) 2022;14:5022. [PMID: 36291806 DOI: 10.3390/cancers14205022] [Reference Citation Analysis]
3 He F, Yi L, Lai C. Fut7 Promotes Adhesion and Invasion of Acute Lymphoblastic Leukemia Cells through the Integrin/Fak/Akt Pathway. Evid Based Complement Alternat Med 2022;2022:1864116. [PMID: 35795270 DOI: 10.1155/2022/1864116] [Reference Citation Analysis]
4 Mengxuan S, Fen Z, Runming J. Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era. Front Pediatr 2022;10:923419. [DOI: 10.3389/fped.2022.923419] [Reference Citation Analysis]
5 Tian S, Guo Y, Fu J, Li Z, Li J, Tian X, Hussein AF. Prognostic Value of Immunotyping Combined with Targeted Therapy in Patients with Non-Small-Cell Lung Cancer and Establishment of Nomogram Model. Computational and Mathematical Methods in Medicine 2022;2022:1-9. [DOI: 10.1155/2022/3049619] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Pawinska-wasikowska K, Wieczorek A, Balwierz W, Bukowska-strakova K, Surman M, Skoczen S. Blinatumomab as a Bridge Therapy for Hematopoietic Stem Cell Transplantation in Pediatric Refractory/Relapsed Acute Lymphoblastic Leukemia. Cancers 2022;14:458. [DOI: 10.3390/cancers14020458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345